Eva R. Chin

4.8k total citations · 1 hit paper
62 papers, 3.7k citations indexed

About

Eva R. Chin is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Eva R. Chin has authored 62 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Physiology and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Eva R. Chin's work include Muscle Physiology and Disorders (28 papers), Cardiomyopathy and Myosin Studies (13 papers) and Adipose Tissue and Metabolism (11 papers). Eva R. Chin is often cited by papers focused on Muscle Physiology and Disorders (28 papers), Cardiomyopathy and Myosin Studies (13 papers) and Adipose Tissue and Metabolism (11 papers). Eva R. Chin collaborates with scholars based in United States, Canada and Australia. Eva R. Chin's co-authors include David G. Allen, R. Sanders Williams, Rhonda Bassel‐Duby, Robin N. Michel, Caroline G. Humphries, John M. Shelton, James A. Richardson, Quan Yang, Haiyan Wu and Eric N. Olson and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Eva R. Chin

60 papers receiving 3.7k citations

Hit Papers

A calcineurin-dependent transcriptional pathway controls ... 1998 2026 2007 2016 1998 250 500 750

Peers

Eva R. Chin
Christopher W. Ward United States
Joseph M. Metzger United States
Brian Glancy United States
Mark A. Anderson United States
Creed M. Stary United States
Christopher W. Ward United States
Eva R. Chin
Citations per year, relative to Eva R. Chin Eva R. Chin (= 1×) peers Christopher W. Ward

Countries citing papers authored by Eva R. Chin

Since Specialization
Citations

This map shows the geographic impact of Eva R. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva R. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva R. Chin more than expected).

Fields of papers citing papers by Eva R. Chin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva R. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva R. Chin. The network helps show where Eva R. Chin may publish in the future.

Co-authorship network of co-authors of Eva R. Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Eva R. Chin. A scholar is included among the top collaborators of Eva R. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva R. Chin. Eva R. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pugsley, Michael K., et al.. (2025). A characterization of aficamten, a cardiac myosin inhibitor, in core battery safety pharmacology studies. Journal of Pharmacological and Toxicological Methods. 133. 107611–107611. 1 indexed citations
2.
Heuberger, Jules A. A. C., John B. Hutchison, Klaus Gjervig Jensen, et al.. (2024). Safety, Pharmacokinetics, and Pharmacodynamics of a First‐in‐Class ClC‐1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial. Clinical Pharmacology & Therapeutics. 117(3). 768–778. 1 indexed citations
3.
Hartman, James J., Darren T. Hwee, Jingying Wang, et al.. (2020). Characterization of the Cardiac Myosin Inhibitor CK-3773274: a Potential Therapeutic Approach for Hypertrophic Cardiomyopathy. Biophysical Journal. 118(3). 596a–596a. 8 indexed citations
4.
Amici, David R., Iago Pinal‐Fernandez, Davi A. G. Mázala, et al.. (2017). Calcium dysregulation, functional calpainopathy, and endoplasmic reticulum stress in sporadic inclusion body myositis. Acta Neuropathologica Communications. 5(1). 24–24. 36 indexed citations
6.
Mázala, Davi A. G., Stephen J. P. Pratt, Dapeng Chen, et al.. (2015). SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models. American Journal of Physiology-Cell Physiology. 308(9). C699–C709. 51 indexed citations
7.
Bamman, Marcas M., Dan M. Cooper, Frank W. Booth, et al.. (2014). Exercise Biology and Medicine: Innovative Research to Improve Global Health. Mayo Clinic Proceedings. 89(2). 148–153. 31 indexed citations
8.
Chin, Eva R.. (2010). Intracellular Ca2+ Signaling in Skeletal Muscle. Exercise and Sport Sciences Reviews. 38(2). 76–85. 37 indexed citations
9.
Cairns, Simeon P., Eva R. Chin, & Jean‐Marc Renaud. (2007). Stimulation pulse characteristics and electrode configuration determine site of excitation in isolated mammalian skeletal muscle: implications for fatigue. Journal of Applied Physiology. 103(1). 359–368. 37 indexed citations
10.
Chakkalakal, Joe V., et al.. (2006). Targeted inhibition of Ca2+/calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Human Molecular Genetics. 15(9). 1423–1435. 53 indexed citations
11.
Angus, Lindsay, Joe V. Chakkalakal, Alexandre Méjat, et al.. (2005). Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction. American Journal of Physiology-Cell Physiology. 289(4). C908–C917. 71 indexed citations
12.
Hornberger, Troy A., Ryan D. Mateja, Eva R. Chin, Jessica L. Andrews, & Karyn A. Esser. (2004). Aging does not alter the mechanosensitivity of the p38, p70S6k, and JNK2 signaling pathways in skeletal muscle. Journal of Applied Physiology. 98(4). 1562–1566. 44 indexed citations
13.
Michel, Robin N., Shannon E. Dunn, & Eva R. Chin. (2004). Calcineurin and skeletal muscle growth. Proceedings of The Nutrition Society. 63(2). 341–349. 89 indexed citations
14.
Chin, Eva R., Robert W. Grange, Alain R. Simard, et al.. (2003). Alterations in Slow‐Twitch Muscle Phenotype in Transgenic Mice Overexpressing the Ca2+ Buffering Protein Parvalbumin. The Journal of Physiology. 547(2). 649–663. 43 indexed citations
16.
Garry, Daniel J., George A. Ordway, John N. Lorenz, et al.. (1998). Mice without myoglobin. Nature. 395(6705). 905–908. 224 indexed citations
17.
Chin, Eva R. & David G. Allen. (1997). Effects of reduced muscle glycogen concentration on force, Ca2+ release and contractile protein function in intact mouse skeletal muscle.. The Journal of Physiology. 498(1). 17–29. 160 indexed citations
18.
Green, H., et al.. (1995). Failure of short term stimulation to reduce sarcoplasmic reticulum Ca2+-ATPase function in homogenates of rat gastrocnemius. Molecular and Cellular Biochemistry. 146(1). 23–33. 10 indexed citations
19.
Green, H. J., et al.. (1994). Preservation of sarcoplasmic reticulum Ca2+-sequestering function in homogenates of different fibre type composition following sprint activity. Canadian Journal of Physiology and Pharmacology. 72(10). 1231–1237. 11 indexed citations
20.
Green, H.J., et al.. (1992). Time‐dependoent increases in Na+,K+‐ATPase content of low‐frequency‐stimulated rabbit muscle. FEBS Letters. 310(2). 129–131. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026